Emslie-Smith AM - Search Results

1

Metformin and reduced risk of cancer in diabetic patients.

Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Evans JM, et al. Among authors: emslie smith am. BMJ. 2005 Jun 4;330(7503):1304-5. doi: 10.1136/bmj.38415.708634.F7. Epub 2005 Apr 22. BMJ. 2005. PMID: 15849206 Free PMC article. No abstract available.

2

The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration.

Morris AD, Boyle DI, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, MacDonald TM. Morris AD, et al. BMJ. 1997 Aug 30;315(7107):524-8. doi: 10.1136/bmj.315.7107.524. BMJ. 1997. PMID: 9329309 Free PMC article.

3

ABC of arterial and venous disease: vascular complications of diabetes.

Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. Donnelly R, et al. Among authors: emslie smith am. BMJ. 2000 Apr 15;320(7241):1062-6. doi: 10.1136/bmj.320.7241.1062. BMJ. 2000. PMID: 10764371 Free PMC article. Review. No abstract available.

4

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines.

Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD; DARTS/MEMO Collaboration. Emslie-Smith AM, et al. Diabet Med. 2001 Jun;18(6):483-8. doi: 10.1046/j.1464-5491.2001.00509.x. Diabet Med. 2001. PMID: 11472468

5

Quality measurement of care for people with type 2 diabetes in Tayside, Scotland: implications for the new UK general practice contract.

Guthrie B, Emslie-Smith A, Morris A, Fahey T, Sullivan F. Guthrie B, et al. Br J Gen Pract. 2003 Sep;53(494):709-13. Br J Gen Pract. 2003. PMID: 15103879 Free PMC article.

6

Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.

James P, Tan HH, MacAlpine R, Brennan G, Emslie-Smith A, Morris AD. James P, et al. Diabet Med. 2004 Oct;21(10):1108-12. doi: 10.1111/j.1464-5491.2004.01301.x. Diabet Med. 2004. PMID: 15384958

7

The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes.

McAlpine RR, Morris AD, Emslie-Smith A, James P, Evans JM. McAlpine RR, et al. Diabet Med. 2005 Mar;22(3):348-52. doi: 10.1111/j.1464-5491.2004.01391.x. Diabet Med. 2005. PMID: 15717888

8

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Evans JM, et al. Diabetologia. 2006 May;49(5):930-6. doi: 10.1007/s00125-006-0176-9. Epub 2006 Mar 9. Diabetologia. 2006. PMID: 16525843 Free article.

9

Stratification of foot ulcer risk in patients with diabetes: a population-based study.

Leese GP, Reid F, Green V, McAlpine R, Cunningham S, Emslie-Smith AM, Morris AD, McMurray B, Connacher AC. Leese GP, et al. Among authors: emslie smith am. Int J Clin Pract. 2006 May;60(5):541-5. doi: 10.1111/j.1368-5031.2006.00899.x. Int J Clin Pract. 2006. PMID: 16700850

10

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Colhoun HM; SDRN Epidemiology Group. Colhoun HM, et al. Diabetologia. 2009 Sep;52(9):1755-65. doi: 10.1007/s00125-009-1453-1. Epub 2009 Jul 15. Diabetologia. 2009. PMID: 19603149 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters